	A multicenter, randomized, parallel-controlled clinical trial protocol to evaluate the safety and efficacy of irreversible electroporation compared with radiofrequency ablation for the treatment of small hepatocellular carcinoma. World J Surg Oncol Cheng C, Xu M, Pan J, Chen Q, Li K, Xu D, Jing X, Lu Q, Yang H, Zhao Q, Deng Z, Jiang T. PMID: 39707376 [PubMed - indexed for MEDLINE]
	Efficacy of adjuvant chemotherapy after curative hepatectomy for patients with colorectal cancer liver metastases: a single-center retrospective study. World J Surg Oncol Inoue A, Nishizawa Y, Hashimoto M, Ozato Y, Morimoto Y, Tomokuni A, Motoori M, Fujitani K. PMID: 39707366 [PubMed - indexed for MEDLINE]
	Non-Invasive Tumor-Naïve Minimal Residual Disease Detection of Liver Cancer by Incorporating Circulating Tumor DNA Features and Alpha-Fetoprotein: A Prospective Study. Cancer Med Ren Q, Li S, Zhong G, Li Y, Huang DL, Zhang L, Feng Y, Long G, Mao M. PMID: 39704423 [PubMed - indexed for MEDLINE]
	A diet-wide association study for liver cancer risk: findings from a prospective cohort study in Chinese women. J Nutr Sci Tuo JY, Shen QM, Li ZY, Tan JY, Tan YT, Li HL, Xiang YB. PMID: 39703897 [PubMed - indexed for MEDLINE]
	Immune-checkpoint HLA-G gene polymorphisms, 3'-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population. Front Immunol Nadda N, Yadav R, Roy N, Singh N, Kumar S, Paul SB, Gamanagatti S, Saraya A, Shalimar, Nayak B. PMID: 39703498 [PubMed - indexed for MEDLINE]
	Burden of Hepatocellular Carcinoma and Its Underlying Etiologies in China, 1990-2021: Findings From the Global Burden of Disease Study 2021. Cancer Control Long J, Cui K, Wang D, Qin S, Li Z. PMID: 39703050 [PubMed - indexed for MEDLINE]
	Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study. Cancer Med Hu B, Yang Y, Yao J, Lin G, He Q, Bo Z, Zhang Z, Li A, Wang Y, Chen G, Shan Y. PMID: 39702929 [PubMed - indexed for MEDLINE]
	Laparoscopic hepatectomy versus microwave ablation for multifocal 3-5 cm hepatocellular carcinoma: a multi-centre, real-world study. Int J Surg Wang Z, Pang C, Meng Q, Zhang DZ, Hong ZX, He GB, Yang H, Xiang BD, Li X, Jiang TA, Li K, Tang Z, Huang F, Lu M, Yu XL, Cheng ZG, Liu FY, Han ZY, Dou JP, Wu SS, Yu J, Liang P. PMID: 39699863 [PubMed - indexed for MEDLINE]
	Performance of contrast-enhanced ultrasound liver imaging reporting and data system for differentiation of patients at risk of hepatocellular carcinoma and liver metastasis. Ann Med Huang W, Lin R, Du Z, Wu Z, Ke X, Tang L. PMID: 39699082 [PubMed - indexed for MEDLINE]
	Improving the prediction of patient survival with the aid of residual convolutional neural network (ResNet) in colorectal cancer with unresectable liver metastases treated with bevacizumab-based chemotherapy. Cancer Imaging Chiu SH, Li HC, Chang WC, Wu CC, Lin HH, Lo CH, Chang PY. PMID: 39696483 [PubMed - indexed for MEDLINE]
	Clinical and splenectomy-based treatment outcomes in 40 cases of hepatosplenic T-cell lymphoma: a comprehensive analysis. World J Surg Oncol Mingyue-Chen, Wu M, Yanhui-Xie, Shen L. PMID: 39696449 [PubMed - indexed for MEDLINE]
	Identification and evaluation of plasma exosome RNA biomarkers for non-invasive diagnosis of hepatocellular carcinoma using RNA-seq. BMC Cancer Huang H, Zhang M, Lu H, Chen Y, Sun W, Zhu J, Chen Z. PMID: 39696145 [PubMed - indexed for MEDLINE]
	Preoperative CT-based morphological heterogeneity for predicting survival in patients with colorectal cancer liver metastases after surgical resection: a retrospective study. BMC Med Imaging Xing Q, Cui Y, Liu M, Gu XL, Li XT, Xing BC, Sun YS. PMID: 39696033 [PubMed - indexed for MEDLINE]
	Impact of pure desmoplastic histological growth patterns in colorectal liver metastasis. BMC Cancer Takasu C, Morine Y, Yoshikawa K, Tokunaga T, Nishi M, Kashihara H, Wada Y, Yoshimoto T, Shimada M. PMID: 39696031 [PubMed - indexed for MEDLINE]
	Prediction of Hepatocellular Carcinoma After Hepatitis C Virus Sustained Virologic Response Using a Random Survival Forest Model. JCO Clin Cancer Inform Nakahara H, Ono A, Hayes CN, Shirane Y, Miura R, Fujii Y, Murakami S, Yamaoka K, Bao H, Uchikawa S, Fujino H, Murakami E, Kawaoka T, Miki D, Tsuge M, Oka S, Hiroshima Liver Study Group, TransSCOT Consortium. PMID: 39693579 [PubMed - indexed for MEDLINE]
	Identification of SPP1 (+) macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics. Front Immunol Jin H, Kim W, Yuan M, Li X, Yang H, Li M, Shi M, Turkez H, Uhlen M, Zhang C, Mardinoglu A. PMID: 39691723 [PubMed - indexed for MEDLINE]
	GALAD, or des-gamma-carboxy prothrombin compared with alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in people with chronic liver disease. Cochrane Database Syst Rev Aralica M, Nadarevic T, Colli A, Casazza G, Vrani, Fraquelli M, Poropat G, . PMID: 39688172 [PubMed - indexed for MEDLINE]
	Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma. Front Immunol Peng K, Zhang X, Li Z, Wang Y, Sun HW, Zhao W, Pan J, Zhang XY, Wu X, Yu X, Wu C, Weng Y, Lin X, Liu D, Zhan M, Xu J, Zheng L, Zhang Y, Lu L. PMID: 39687612 [PubMed - indexed for MEDLINE]
	Development and validation of a prognostic nomogram including inflammatory indicators for overall survival in hepatocellular carcinoma patients treated primarily with surgery or loco-regional therapy: A single-center retrospective study. Medicine (Baltimore) Wang X, Xu J, Jia Z, Sun G. PMID: 39686498 [PubMed - indexed for MEDLINE]
	Serum pentraxin-3 as a potential biomarker for diagnosis and prognosis in primary liver cancer: An observational study. Medicine (Baltimore) Chen L, Song S, Chen M, Liu Q, Zhou H. PMID: 39686456 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 70340

Page 1 of 3517



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy